Cargando…
Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Glioblastoma (GBM) as the most common primary malignant brain tumor exhibits a high incidence and degree of malignancy as well as poor prognosis. Due to the existence of formidable blood–brain barrier (BBB) and the aggressive growth and infiltrating nature of GBM, timely diagnosis and treatment of G...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204881/ https://www.ncbi.nlm.nih.gov/pubmed/35710493 http://dx.doi.org/10.1186/s12951-022-01479-6 |